Positron emission tomography with 2-[18f]fluoro-2-deoxy-d-glucose: can it be used to accurately stage the mediastinum in non–small cell lung cancer as an alternative to mediastinoscopy?

This publication has 12 references indexed in Scilit:

• A comparative analysis of positron emission tomography and mediastinoscopy in staging non–small cell lung cancer
  The Journal of Thoracic and Cardiovascular Surgery, 2003
• Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial
  The Lancet, 2002
• Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer?
  The Annals of Thoracic Surgery, 2002
• Clinical Impact of ¹⁸F Fluorodeoxyglucose Positron Emission Tomography in Patients With Non–Small-Cell Lung Cancer: A Prospective Study
  Journal of Clinical Oncology, 2001
• Preoperative Staging of Non–Small-Cell Lung Cancer with Positron-Emission Tomography
  New England Journal of Medicine, 2000
• Prognostic Value of Thoracic FDG PET Imaging After Treatment for Non-Small Cell Lung Cancer
  American Journal of Roentgenology, 2000
• Prognostic Importance of the Standardized Uptake Value on ¹⁸F-Fluoro-2-Deoxy-Glucose–Positron Emission Tomography Scan in Non–Small-Cell Lung Cancer: An Analysis of 125 Cases
  Journal of Clinical Oncology, 1999
• The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma
  Cancer, 1998
• Positron Emission Tomography in Lung Cancer
  The Annals of Thoracic Surgery, 1998
• Mediastinal Lymph Node Staging With FDG-PET Scan in Patients With Potentially Operable Non-small Cell Lung Cancer
  Chest, 1997